Author

Federica Benvenuti

Università di CamerinoPrimary ORCID profile (0000-0002-1908-8052 · 7 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Federica BenvenutiiD7 papers · International Centre for Genetic Engineering and Biotechnology

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:rat· 1

Frequent Co-Authors

Friedbert WeissiD· 1 shared Hongwu Li· 1 shared Laura Soverchia· 1 shared Nazzareno CannellaiD· 1 shared Qianwei SheniD· 1 shared Rajesh NarendraniD· 1 shared Roberto CiccocioppoiD· 1 shared Veronica LunertiiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Friedbert WeissORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyNeuropharmacologyPeer-reviewedJul 25, 2023

Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy

Nazzareno Cannella, Veronica Lunerti, Qianwei Shen…·Roberto Ciccocioppo

This study evaluates cebranopadol's efficacy and abuse liability in treating opioid use disorder using rat models, showing reduced self-administration and stress-induced reinstatement compared to heroin.

9 citations

ratexperimental assay

𝕏 PostBluesky